Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.88 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.88 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.64 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | CA6 | P23280 | 1/20 | 0.62 |
| ▸ | CA7 | P43166 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 1/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL27627921 | 0.97 | ALDH1A1 (0.82) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL532853 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL28122901 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL109124 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL8726392 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL28252361 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL29176753 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL467124 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL105219 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E | |
| Phthalic Acid SCHEMBL7030038 | 0.97 | ALDH1A1 (0.93) | ALDH1A1ALOX15AKR1C3NAPRTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114561258-B | Cleaning agent for alkaline washing tower of ethylene device | 浙江杭化科技股份有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-114561258-A | Ethylene unit alkaline washing tower detergent | 浙江杭化科技股份有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-104971200-A | Tannic acid pH-stable hemorrhoid gel and preparation method thereof | ZHEJIANG HONGYU MEDICAL COMMODITY CO LTD | 2015-10-14 | — | — | CN | claimed |
| CN-202442577-U | Drum drying machine applied for production of potassium sodium hydrogen citrate particle | HEFEI KESHANG MEDICAL TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | claimed |
| CN-202383912-U | Potassium sodium hydrogen citrate double salt hydrate molecular structure model | HEFEI KESHANG MEDICAL TECHNOLOGY CO LTD | 2012-08-15 | — | — | CN | claimed |
| CN-102557921-A | Preparation method of potassium sodium hydrogen citrate complex salt hydrate | HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD | 2012-07-11 | — | — | CN | claimed |
| CN-102226769-A | Reagents used for measuring direct bilirubin through sodium nitrite oxidation method | ZHENGZHOU LABSCIENCE CO LTD | 2011-10-26 | — | — | CN | claimed |
| CN-101190185-A | Alkaline drug enteric preparation and preparation method thereof | DAPENG LI (CN) | 2008-06-04 | — | — | CN | claimed |
| CN-119101158-A | Human PD-L2 antibodies and methods of use thereof | 得克萨斯州大学系统董事会 | 2024-12-10 | — | — | CN | disclosed |
| CN-113423465-B | Therapeutic factor XII antibodies | 俄勒冈健康与科学大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-118974092-A | Bispecific antibodies against human PD-L1 and PD-L2 and methods of use thereof | 得克萨斯州大学系统董事会 | 2024-11-15 | — | — | CN | disclosed |
| CN-111902156-B | Human PD-L2 antibodies and methods of use thereof | 得克萨斯州大学系统董事会 | 2024-11-08 | — | — | CN | disclosed |
| CN-114478756-B | Antibody-mediated neutralization of chikungunya virus | 范德比尔特大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-117881414-A | peptide-FC fusions for the treatment of amyloid disorders | 田纳西大学研究基金会 | 2024-04-12 | — | — | CN | disclosed |
| US-5493009-A | SKIN MELANOMA | NEW YORK MEDICAL COLLEGE (US) | 1996-02-20 | — | — | US | disclosed |
| EP-0428485-B1 | Novel antiidiotypic monoclonal antibodies | NEW YORK MEDICAL COLLEGE (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5296352-A | Monoclonal antibodies directed against complexes formed by thrombin and hirudin | CIBA-GEIGY CORPORATION (US) | 1994-03-22 | — | — | US | disclosed |
| EP-0479721-A2 | Monoclonal antibodies directed against complexes formed by thrombin and thrombin inhibitors | CIBA-GEIGY AG (CH) | 1992-04-08 | — | — | EP | disclosed |
| EP-0428485-A1 | Novel antiidiotypic monoclonal antibodies | NEW YORK MEDICAL COLLEGE (US) | 1991-05-22 | — | — | EP | disclosed |
| EP-0392976-A1 | Monoclonal antibodies to tetracyclic compounds, processes for their production, and applications | CIBA-GEIGY AG (CH) | 1990-10-17 | — | — | EP | disclosed |